Company: Bystro
Founder: Alex Kotlar
Website: https://www.bystro.io
About Bystro
Bystro was founded to solve one of the biggest problems in modern medicine. While DNA sequencing has become faster and less expensive, making sense of that data has remained slow, expensive, and limited to a small group of specialists. The team saw an opportunity to change that by making advanced genetic analysis as simple as asking a question in plain English.
From the beginning, the challenge was not just building better technology. It was changing the way researchers interact with genetic data. Scientists often work in highly specialized fields, with different teams focused on genetics, imaging, metabolism, RNA, or clinical care. Valuable information is spread across many disciplines, making collaboration difficult. Bystro was built to remove those barriers by giving researchers a faster, more accessible way to search, analyze, and understand massive genomic datasets.
Like many deep technology startups, Bystro faced the challenge of earning trust in a field where accuracy and reproducibility are essential. The platform was developed alongside researchers and refined through real world use in academic environments. Today, it has been deployed at the Emory Brain Health Institute and the UC Davis Idea Lab, where it supports research into Alzheimers disease by making genetic analysis accessible to scientists who are not genetics specialists.
Bystro has helped shift expectations across the HealthTech industry by proving that artificial intelligence can make complex biomedical data easier to understand without sacrificing scientific rigor. Instead of requiring specialized coding skills or bioinformatics training, researchers can interact with genomic data through natural language, allowing more members of a research team to contribute meaningful insights.
The company is helping accelerate discovery in precision medicine, rare disease research, and neurodegenerative disease while making genomic analysis faster, more reproducible, and more collaborative. As the amount of biological data continues to grow, Bystro is building the tools that allow researchers to spend less time wrestling with data and more time making discoveries that improve patient care.
Want to find out what TechRound can do for your business?
